SANDRIVETTE JOHNSON: Open Payments
NPI 1740201458 · RALEIGH, NC. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$107,476 in 325 payments from 22 companies in 2025. Trend: 2023 $140,166 · 2024 $174,158 · 2025 $107,476
Speaker / faculty: $61,506Consulting: $26,342Travel & lodging: $10,140Food & beverage: $6,346Honoraria: $2,940Gift: $117
| Company | Payments | Amount |
|---|---|---|
| Janssen Biotech, Inc. | 46 | $18,674 |
| Arcutis Biotherapeutics, Inc. | 17 | $13,546 |
| Lilly USA, LLC | 26 | $12,411 |
| ABBVIE INC. | 51 | $10,260 |
| GENZYME CORPORATION | 24 | $8,308 |
| Eli Lilly and Company | 6 | $6,235 |
| Amgen Inc. | 19 | $6,034 |
| Galderma Laboratories, L.P. | 13 | $5,657 |
| UCB, Inc. | 14 | $5,489 |
| LEO Pharma Inc. | 28 | $5,458 |
Products named: TREMFYA, EBGLYSS, Zoryve, DUPIXENT, RINVOQ, NEMLUVIO, Bimzelx, ZELSUVMI.
Industry payments across NC — which companies pay providers there.
